Lakefront Biotherapeutics (LKFT) Debt Ratio (2020)

Lakefront Biotherapeutics (LKFT) has reported Debt Ratio for 6 consecutive years, with 0.0 the latest figure, recorded in Q4 2025.

• In Q4 2025, Debt Ratio rose 21.41% year-over-year to 0.0; the TTM figure through Dec 2025 stood at 0.0 (up 21.41% YoY), while the FY2025 annual figure was 0.0, up 21.41% from the prior year.
• Debt Ratio rose to 0.0 in Q4 2025 per LKFT's latest filing, from 0.0 in the prior quarter.
• Across five years, Debt Ratio topped out at 0.0 in Q1 2022 and bottomed at 0.0 in Q4 2024.
• Historically, Debt Ratio has averaged 0.0 across 4 years, with a median of 0.0 in 2021.
• Annual changes were most pronounced in 2021 — Debt Ratio sank 98.67% — and 2025, when it increased 21.41%.
• Lakefront Biotherapeutics' Debt Ratio stood at 0.0 in 2021, then jumped by 94.16% to 0.0 in 2022, then sank by 98.41% to 0.0 in 2024, then climbed by 21.41% to 0.0 in 2025.
• Business Quant data shows LKFT's Debt Ratio at 0.0 in Q4 2025, 0.0 in Q4 2024, and 0.0 in Q1 2022.